AlphaRaccoon's username was removed from the Polymarket account after users on Discord and X speculated that the trader may have been a Google insider.AlphaRaccoon's username was removed from the Polymarket account after users on Discord and X speculated that the trader may have been a Google insider.

Google Engineer Accused of Turning Secret Search Data Into a $1.2M Polymarket Profit

2026/05/29 07:45
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

US prosecutors have charged Google software engineer Michele Spagnuolo, also known online as ‘AlphaRaccoon,’ with allegedly using confidential internal Google search data to profit roughly $1.2 million through bets placed on prediction market platform Polymarket.

According to a criminal complaint unsealed in the Southern District of New York, Spagnuolo allegedly accessed nonpublic ‘Year in Search 2025’ data from Google’s internal systems and used that information to trade on Google-related markets on Polymarket before the results became public.

Polymarket Insider Trading Case

Prosecutors charged him with commodities fraud, wire fraud, and money laundering, while the Commodity Futures Trading Commission (CFTC) filed a parallel civil complaint accusing him of insider trading violations under the Commodity Exchange Act. The filing states that Google keeps its “Year in Search” rankings strictly confidential because the annual campaign is commercially valuable and designed around a coordinated public reveal intended to generate media attention, user engagement, and advertising demand.

Investigators said Spagnuolo had access to a Google internal software tool containing confidential trend data and that the tool itself displayed a “Google Confidential” warning banner. Authorities allege that between October and December 2025, Spagnuolo used the AlphaRaccoon Polymarket account to place bets on at least 23 Google-related prediction markets, including contracts tied to the “#1 Searched Person on Google this year” and “Top 5 Most Searched People on Google 2025.”

The complaint says that after reviewing Google’s internal data on October 15, 2025, Spagnuolo placed trades the following day, backing Kendrick Lamar to become the top searched person of the year while simultaneously betting against Pope Leo XIV achieving the same result. Prosecutors said he continued placing trades over the following weeks using knowledge unavailable to the public.

On November 27, 2025, investigators allege that Spagnuolo again accessed confidential Google search rankings and learned that musician d4vd had overtaken Kendrick Lamar as the top trending person for the year. Roughly three hours later, the AlphaRaccoon account allegedly placed bets favoring d4vd despite the market assigning almost no probability to that outcome at the time.

The filing states that the account risked roughly $2.75 million across Google Year in Search-related markets between October 15 and December 4, 2025. After Google publicly released its Year in Search results on December 4, prosecutors said the AlphaRaccoon account generated approximately $1.2 million in profits.

Investigators further allege that Spagnuolo attempted to conceal the origin of the proceeds by moving crypto through multiple wallets, decentralized swapping services, and a privacy-focused transfer service.

Kalshi’s Crackdown on Insider Trading Cases

The allegations against Spagnuolo come as prediction markets face increasing scrutiny over insider-style trading activity. In April, rival platform Kalshi banned three US political candidates after discovering they had placed bets tied to their own election races. Those included Minnesota State Senator Matt Klein, Texas congressional candidate Ezekiel Enriquez, and Virginia Senate candidate Mark Moran.

Kalshi said the trades violated exchange rules that prohibit people with direct influence over an event from trading related contracts. The platform issued fines and five-year bans.

The post Google Engineer Accused of Turning Secret Search Data Into a $1.2M Polymarket Profit appeared first on CryptoPotato.

SPACEX(PRE) Launchpad

SPACEX(PRE) LaunchpadSPACEX(PRE) Launchpad

Register for a chance to win a free lucky draw

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin is poised for a reversal if ETF demand returns or a ceasefire occurs, potentially crushing short sellers in a massive price squeeze.
Share
Coin Telegraph2026/04/04 19:58
Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Inertia is the invisible tax on modern industrial throughput. Every millisecond a robotic arm spends decelerating, or waiting for high-frequency vibrations to settle
Share
Techbullion2026/04/02 18:25

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage